1123648

Gregory A. Otterson, M.D. — FEI 3016543845

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 24, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Columbus, OH (United States)

Additional Details

Clinical Investigator (CI)